Pacific Biosciences of California, Inc. Share-based Payment Arrangement, Expense
Pacific Biosciences of California, Inc. (PACB) reported Share-based Payment Arrangement, Expense of $9.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $9.26M, a 22.13% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $10.98M, a 39.84% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $11.89M, a 30.92% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $18.26M, a 7.27% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for fiscal 2023 was $72.12M, a 8.26% decline from fiscal 2022.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for fiscal 2022 was $78.61M, a 2.62% decline from fiscal 2021.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for fiscal 2021 was $80.73M, a 360.43% increase from fiscal 2020.
- Pacific Biosciences of California, Inc. share-based payment arrangement, expense for fiscal 2020 was $17.53M, a 6.90% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.26M 10-Q · filed 2026-08-06 | $13.72M 10-Q · filed 2026-08-06 | ||
| 2025-09-30 | $10.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.88M derived: sum of 2 quarters · filed 2026-08-06 | $32.08M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $11.89M 10-Q · filed 2026-08-06 | $21.10M 10-Q · filed 2026-08-06 | ||
| 2024-09-30 | $18.26M 10-Q · filed 2024-11-12 | $35.48M derived: sum of 2 quarters · filed 2024-11-12 | $55.00M 10-Q · filed 2025-11-06 | $71.59M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $17.22M 10-Q · filed 2024-08-09 | $36.74M 10-Q · filed 2025-08-07 | $53.33M derived: sum of 3 quarters · filed 2024-08-09 | $73.02M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $19.52M 10-Q · filed 2024-05-09 | $36.11M derived: sum of 2 quarters · filed 2024-05-09 | $55.80M derived: sum of 3 quarters · filed 2024-11-12 | $73.69M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $36.27M derived: sum of 2 quarters · filed 2024-11-12 | $54.17M derived: sum of 3 quarters · filed 2024-11-12 | $72.12M 10-K · filed 2024-02-28 |
| 2023-09-30 | $19.69M 10-Q · filed 2024-11-12 | $37.58M derived: sum of 2 quarters · filed 2024-11-12 | $55.53M 10-Q · filed 2024-11-12 | $73.49M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $17.89M 10-Q · filed 2024-08-09 | $35.84M 10-Q · filed 2024-08-09 | $53.80M derived: sum of 3 quarters · filed 2024-08-09 | $72.73M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $17.95M 10-Q · filed 2024-05-09 | $35.91M derived: sum of 2 quarters · filed 2024-05-09 | $54.84M derived: sum of 3 quarters · filed 2024-05-09 | $73.86M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $36.89M derived: sum of 2 quarters · filed 2024-02-28 | $55.91M derived: sum of 3 quarters · filed 2024-02-28 | $78.61M 10-K · filed 2024-02-28 |
| 2022-09-30 | $18.94M 10-Q · filed 2023-11-03 | $37.95M derived: sum of 2 quarters · filed 2023-11-03 | $60.66M 10-Q · filed 2023-11-03 | $79.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $19.02M 10-Q · filed 2023-08-04 | $41.72M 10-Q · filed 2023-08-04 | $60.66M derived: sum of 3 quarters · filed 2024-02-28 | $96.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $22.70M 10-Q · filed 2023-05-04 | $41.64M derived: sum of 2 quarters · filed 2024-02-28 | $77.46M derived: sum of 3 quarters · filed 2024-02-28 | $93.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $18.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $54.76M derived: sum of 2 quarters · filed 2024-02-28 | $70.56M derived: sum of 3 quarters · filed 2024-02-28 | $80.73M 10-K · filed 2024-02-28 |
| 2021-09-30 | $35.82M 10-Q · filed 2021-11-05 | $51.63M derived: sum of 2 quarters · filed 2022-08-08 | $61.79M 10-Q · filed 2021-11-05 | $67.06M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $15.80M 10-Q · filed 2022-08-08 | $25.97M 10-Q · filed 2022-08-08 | $31.25M derived: sum of 3 quarters · filed 2023-02-28 | $36.24M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $10.16M 10-Q · filed 2022-05-06 | $15.44M derived: sum of 2 quarters · filed 2023-02-28 | $20.43M derived: sum of 3 quarters · filed 2023-02-28 | $23.67M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $10.27M derived: sum of 2 quarters · filed 2023-02-28 | $13.50M derived: sum of 3 quarters · filed 2023-02-28 | $17.53M 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.99M 10-Q · filed 2021-11-05 | $8.23M derived: sum of 2 quarters · filed 2021-11-05 | $12.26M 10-Q · filed 2021-11-05 | $16.13M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $3.23M 10-Q · filed 2021-08-06 | $7.27M 10-Q · filed 2021-08-06 | $11.13M derived: sum of 3 quarters · filed 2022-02-28 | $15.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.03M 10-Q · filed 2021-05-06 | $7.90M derived: sum of 2 quarters · filed 2022-02-28 | $11.96M derived: sum of 3 quarters · filed 2022-02-28 | $16.05M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $7.93M derived: sum of 2 quarters · filed 2022-02-28 | $12.02M derived: sum of 3 quarters · filed 2022-02-28 | $16.40M 10-K · filed 2022-02-28 |
| 2019-09-30 | $4.06M 10-Q · filed 2020-11-03 | $8.15M derived: sum of 2 quarters · filed 2020-11-03 | $12.53M 10-Q · filed 2020-11-03 | $20.05M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $4.09M 10-Q · filed 2020-08-06 | $8.47M 10-Q · filed 2020-08-06 | $15.99M derived: sum of 3 quarters · filed 2021-02-26 | $21.12M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $4.38M 10-Q · filed 2020-05-08 | $11.90M derived: sum of 2 quarters · filed 2021-02-26 | $17.03M derived: sum of 3 quarters · filed 2021-02-26 | $22.25M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $12.65M derived: sum of 2 quarters · filed 2021-02-26 | $17.87M derived: sum of 3 quarters · filed 2021-02-26 | $23.15M 10-K · filed 2021-02-26 |
| 2018-09-30 | $5.13M 10-Q · filed 2019-11-07 | $10.35M derived: sum of 2 quarters · filed 2019-11-07 | $15.63M 10-Q · filed 2019-11-07 | $21.02M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $5.22M 10-Q · filed 2019-08-06 | $10.51M 10-Q · filed 2019-08-06 | $15.90M derived: sum of 3 quarters · filed 2020-02-28 | $20.86M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $5.28M 10-Q · filed 2019-05-03 | $10.67M derived: sum of 2 quarters · filed 2020-02-28 | $15.64M derived: sum of 3 quarters · filed 2020-02-28 | $20.65M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $10.36M derived: sum of 2 quarters · filed 2020-02-28 | $15.37M derived: sum of 3 quarters · filed 2020-02-28 | $20.35M 10-K · filed 2020-02-28 |
| 2017-09-30 | $4.97M 10-Q · filed 2018-11-05 | $9.98M derived: sum of 2 quarters · filed 2018-11-05 | $14.96M 10-Q · filed 2018-11-05 | $19.80M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $5.01M 10-Q · filed 2018-08-03 | $9.99M 10-Q · filed 2018-08-03 | $14.83M derived: sum of 3 quarters · filed 2019-02-26 | $19.94M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $4.98M 10-Q · filed 2018-05-02 | $9.82M derived: sum of 2 quarters · filed 2019-02-26 | $14.93M derived: sum of 3 quarters · filed 2019-02-26 | $19.96M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $9.94M derived: sum of 2 quarters · filed 2019-02-26 | $14.98M derived: sum of 3 quarters · filed 2019-02-26 | $19.56M 10-K · filed 2019-02-26 |
| 2016-09-30 | $5.11M 10-Q · filed 2017-11-02 | $10.14M derived: sum of 2 quarters · filed 2017-11-02 | $14.73M 10-Q · filed 2017-11-02 | $18.75M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $5.04M 10-Q · filed 2017-08-02 | $9.62M 10-Q · filed 2017-08-02 | $13.65M derived: sum of 3 quarters · filed 2018-02-26 | $16.88M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $4.58M 10-Q · filed 2017-05-05 | $8.61M derived: sum of 2 quarters · filed 2018-02-26 | $11.85M derived: sum of 3 quarters · filed 2018-02-26 | $15.17M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.26M derived: sum of 2 quarters · filed 2018-02-26 | $10.59M derived: sum of 3 quarters · filed 2018-02-26 | $13.84M 10-K · filed 2018-02-26 |
| 2015-09-30 | $3.24M 10-Q · filed 2016-11-04 | $6.56M derived: sum of 2 quarters · filed 2016-11-04 | $9.81M 10-Q · filed 2016-11-04 | $12.81M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $3.32M 10-Q · filed 2016-08-04 | $6.58M 10-Q · filed 2016-08-04 | $9.57M derived: sum of 3 quarters · filed 2017-03-06 | $12.03M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $3.25M 10-Q · filed 2016-05-05 | $6.25M derived: sum of 2 quarters · filed 2017-03-06 | $8.71M derived: sum of 3 quarters · filed 2017-03-06 | $10.93M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $5.45M derived: sum of 2 quarters · filed 2017-03-06 | $7.67M derived: sum of 3 quarters · filed 2017-03-06 | $9.94M 10-K · filed 2017-03-06 |
| 2014-09-30 | $2.45M 10-Q · filed 2015-11-05 | $4.67M derived: sum of 2 quarters · filed 2015-11-05 | $6.94M 10-Q · filed 2015-11-05 | $9.49M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $2.22M 10-Q · filed 2015-08-05 | $4.49M 10-Q · filed 2015-08-05 | $7.04M derived: sum of 3 quarters · filed 2016-03-11 | $9.21M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $2.27M 10-Q · filed 2015-05-05 | $4.81M derived: sum of 2 quarters · filed 2016-03-11 | $6.99M derived: sum of 3 quarters · filed 2016-03-11 | $9.43M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $4.71M derived: sum of 2 quarters · filed 2016-03-11 | $7.16M derived: sum of 3 quarters · filed 2016-03-11 | $9.90M 10-K · filed 2016-03-11 |
| 2013-09-30 | $2.17M 10-Q · filed 2014-11-05 | $4.62M derived: sum of 2 quarters · filed 2014-11-05 | $7.36M 10-Q · filed 2014-11-05 | $9.91M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $2.44M 10-Q · filed 2014-08-05 | $5.19M 10-Q · filed 2014-08-05 | $7.74M derived: sum of 3 quarters · filed 2015-03-12 | $10.13M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $2.75M 10-Q · filed 2014-05-08 | $5.29M derived: sum of 2 quarters · filed 2015-03-12 | $7.68M derived: sum of 3 quarters · filed 2015-03-12 | $10.26M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.93M derived: sum of 2 quarters · filed 2015-03-12 | $7.52M derived: sum of 3 quarters · filed 2015-03-12 | $9.71M 10-K · filed 2015-03-12 |
| 2012-09-30 | $2.39M 10-Q · filed 2013-11-12 | $4.97M derived: sum of 2 quarters · filed 2013-11-12 | $7.16M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $2.58M 10-Q · filed 2013-08-09 | $4.77M 10-Q · filed 2013-08-09 | ||
| 2011-12-31 | $12.38M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |